Vulvar Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-09
Clinical Trial Update: Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant pembrolizumab in vulvar squamous cell carcinoma as a proof-of-concept study.